共 116 条
[1]
Campbell SC(2021)Renal mass and localized renal cancer: evaluation, management, and follow-up: AUA guideline: part I J Urol. 206 199-208
[2]
Clark PE(2022)Kidney cancer, version 3.2022, NCCN clinical practice guidelines in oncology J Natl Compr Canc Netw. 20 71-90
[3]
Chang SS(2020)Society of interventional radiology quality improvement standards on percutaneous ablation in renal cell carcinoma J Vasc Interv Radiol. 31 195-201.e3
[4]
Karam JA(2018)Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries CA Cancer J Clin. 68 394-424
[5]
Souter L(2021)Role of imaging in renal cell carcinoma: a multidisciplinary perspective Radiographics. 41 1387-1407
[6]
Uzzo RG(2014)Role of combined embolization and ablation in management of renal masses Semin Intervent Radiol. 31 82-85
[7]
Motzer RJ(2000)Combined embolization and percutaneous radiofrequency ablation of a solid renal tumor AJR Am J Roentgenol. 174 1592-1594
[8]
Jonasch E(2007)Radiofrequency ablation in combination with embolization in metachronous recurrent renal cancer in solitary kidney after contralateral tumor nephrectomy Cardiovasc Intervent Radiol. 30 644-649
[9]
Agarwal N(2001)Nephron-sparing percutaneous ablation of a 5 cm renal cell carcinoma by superselective embolization and percutaneous RF-ablation Rofo. 173 980-983
[10]
Alva A(2007)Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up Int J Urol. 14 585-590